Our off-label case (NovoSeven) against Novo Nordisk is generating a lot of press.
See the San Antonio Express-News.
See the Baltimore Sun.
Of course, Novo Nordisk was clever and had a press release ready to roll out the moment the case was unsealed. Thus, the first-run articles in the Wall Street Journal, AP, Reuters and others wrote soley based upon the information provided by Novo Nordisk's press release.
At the time those articles were written, the DoJ had yet to publish the press release. Click here for the DoJ press release.